News

Biotech Beyond Borders report provides a sobering snapshot of the industry’s financial health, with more and more companies ...
SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd ...
SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd ...
pharmaand GmbH (pharma&) has received a regulatory variation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), authorizing its wholly owned subsidiary, Loba biotech GmbH, as an ...
Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering.. The ...
Angela Hwang on her pivot from Big Pharma to biotech By Ayla Ellison, Angus Liu May 9, 2025 8:33am The Top Line Angela Hwang Pfizer Flagship Pioneering ...
Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering. This ...
The Pharma AI Council officially launched today, establishing a new force to drive innovation and the responsible application of AI in the life sciences industry. PAC is dedicated to shaping the ...
Pharmaceutical tariffs are likely to drive up drug prices and worsen shortages in the U.S.
LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a ...
Pharma, biotech recruitment consideration. In addition to the affirmative action reversal and funding constraints, BIPOC leaders face a recruitment conundrum, too. From a talent perspective, the ...
The U.S. imports many of its pharmaceuticals from abroad. It imported $213-billion-worth of medicines in 2024 with little to no import tax because of a 1995 World Trade Organization agreement.